Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
While selenium deficiency is a major etiological factor of Keshan disease (54), the seasonal and annual variation in disease occurrence suggested that other factors, especially an infectious agent, might be involved in addition to selenium deficiency (55)
This is a thrilling and dynamic field, and the impulse to combine tools to achieve a greater effect is at the very heart of scientific discovery
Personalised Protocols Based on your diagnostics, lifestyle, and personal goals, we carefully tailor glutathione doses and accompanying nutrients in our IV infusions
## Availability Status: March 2026 - **FDA status:** Phase 3 clinical trials ongoing - **Expected approval timeline:** Potentially 2026-2027 - **Brand availability:** None yet - **Current access:** Compounding pharmacies (503A/503B) with valid prescription For a detailed breakdown of [retatrutide's FDA approval status and projected timeline](/guides/retatrutide-fda-approval-2026-timeline-status), see our dedicated tracker the date brand pricing becomes available depends directly on when retatrutide clears FDA review
US$ 24.60
US$ 23.30
US$ 29.65
US$ 27.69
US$ 24.90
US$ 27.49
